Search results for: 'pakistani pharma industry analysis'

The pharmaceutical and biotechnology industries are entering a transformative era in 2025, shaped by a convergence of scientific innovation, regulatory evolution, and market pressures. One of the key imperatives is the continued advancement of therapeutics and drug approvals, as breakthrough treatments, particularly in personalized medicine, promis...

The report provides an indepth analysis of each trend, outlining market demands, drivers and restraints, growth opportunities, and use cases. This will help vendors analyze the market, evaluate their market positioning, and take appropriate action to become global leaders.--BEGIN PROMO--Research Scope This study examines the market scenario and ...

The space industry is no longer sustained by governmental bodies and aerospace and defense companies. In the modern space race, the private sector is dominating by discovering new opportunities regarding innovations and public-private partnerships. The term “NewSpace” heralds the arrival of private space company ventures. Start-ups, investors, ...

The global space industry has been expanding with the entry of new participants and non-space companies that are extending their roles to cater to both the upstream and the downstream segments. The upstream segment is expanding exponentially and is seeing successful launches by low earth orbit (LEO) satellite constellation operators as well as plan...

This study assesses the automotive market in China, focusing on the passenger vehicle (PV) market. Within this, Frost & Sullivan will also discuss electric vehicles (EVs), charging, and battery swapping. China’s automotive market has proliferated, particularly after the 2008 Beijing Olympics. The unit shipment of China’s PV market has consiste...

Top growth opportunities in the Aerospace & Defense program area cover the commercial aviation, spacecraft, unmanned systems, and defense markets. Technologies and services often overlap, and industry participants will have opportunities with civilian and military customers in 2023. The commercial aviation industry is on the rebound, with increasin...

This deliverable provides insights on the many macro issues facing the pharma and biotech industry. The industry is currently in a state of transition and is faced with a myraid of challenges including the dreaded patent cliff. This research service presents a total market forecast, market share analysis by leading companies, top therapeutic class...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...